Try our beta test site
1562 studies found for:    cancer | bevacizumab
Show Display Options
Rank Status Study
21 Active, not recruiting Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients
Condition: Metastatic Breast Cancer
Interventions: Drug: low-dose-bevacizumab/pemetrexed;   Drug: Treatment of physician's choice
22 Completed
Has Results
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Condition: Prostate Cancer
Interventions: Biological: bevacizumab;   Drug: satraplatin
23 Recruiting An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus. mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer.
Condition: Colorectal Cancer
Interventions: Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab;   Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
24 Completed Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab + doxorubin hydrochloride liposme;   Drug: Bevacizumab
25 Completed Bendamustine and Bevacizumab for Advanced Cancers
Condition: Advanced Cancer
Interventions: Drug: Bendamustine;   Drug: Bevacizumab
26 Completed
Has Results
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
Condition: Prostate Cancer
Intervention: Drug: Erlotinib + Bevacizumab
27 Completed Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Radiation: Radiotherapy
28 Completed First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
29 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
30 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
31 Completed
Has Results
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Bevacizumab
32 Recruiting Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment
Conditions: Neoplasm;   Colorectal Cancer;   Metastatic Neoplasm
Intervention: Drug: Bevacizumab
33 Completed
Has Results
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Bevacizumab
34 Terminated Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: ixabepilone;   Drug: bevacizumab
35 Active, not recruiting
Has Results
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Condition: Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Bevacizumab;   Drug: Docetaxel
36 Completed Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: bevacizumab, erlotinib
37 Completed Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
Condition: Colorectal Cancer
Intervention: Drug: S-1, Bevacizumab
38 Recruiting Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Bevacizumab plus alternating Xelox/Xeliri
39 Completed
Has Results
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Standard adjuvant chemotherapy
40 Completed Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Bevacizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.